Britton Plemmons, DPM
Foot & Ankle Surgery · Longview, TXNPI 1093154189
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $64,725 of the $87,095 with a category attached, or 74.3%. 16 manufacturers reported payments, led by Medshape, Inc. at 43.6% of the total. Among foot & ankle surgery clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 172 payments — averaging $506.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medshape, Inc.$38K
- Trilliant Surgical LLC.$19K
- Medical Device Business Services, Inc.$11K
- Pylant Medical$7K
- Smith+Nephew$7K
- Stryker$3K
- plus $3K from 10 others
What the payments were for
- Consulting fees$64,72574%
- Travel & lodging$11,01213%
- Food & beverage$4,6925%
- Education$6,6668%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medshape, Inc. | 46 | $37,960 |
| Trilliant Surgical LLC. | 19 | $18,661 |
| Medical Device Business Services, Inc. | 10 | $10,577 |
| Pylant Medical | 16 | $7,278 |
| Smith+Nephew | 11 | $7,218 |
| Stryker | 38 | $2,706 |
| Vilex LLC | 13 | $1,786 |
| Bioventus LLC | 7 | $271 |
| Triad Life Sciences Inc. | 1 | $191 |
| Johnson & Johnson | 4 | $146 |
| Convatec Inc. | 1 | $137 |
| Alafair Biosciences, Inc. | 2 | $64 |
| Ossio Inc | 1 | $52 |
| Ferring Pharmaceuticals Inc. | 1 | $19 |
| Ultragenyx Pharmaceutical Inc. | 1 | $17 |
| Amgen | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DynaNail Helix, Washer, 15 mm$32,385
- DynaNail$19,679
- Arsenal Sinus Support Plate$10,080
- NA$9,450
- Arsenal Ankle 10 Hole 1/3 Tubular Plate$7,414
- HINTERMANN$1,318
- INFINITY$958
- PROPHECY$757
- Arsenal Ankle$357
- DynaNail Mini$308
- InnovaMatrix AC$191
- INBONE$166
- AQUACEL Ag Surgical$137
How this compares
$87,095 in reported general payments places this provider in the 95th percentile of 684 foot & ankle surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 145 | $1,168 |
| Terbinafine Hcl | 31 | $459 |
| Ondansetron Hcl | 67 | $328 |
| Tramadol Hcl | 90 | $297 |
| Cephalexin | 40 | $271 |
| Gabapentin | 51 | $229 |
| Meloxicam | 91 | $198 |
| Levofloxacin | 30 | $185 |
| Methylprednisolone | 22 | $145 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 13 | $73 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Longview
- William McGarveyKaty$3.5M
- Eugene CurryDallas$3.1M
- Graham HamiltonEdinburg$2.1M
- Mark DaltonAustin$1.9M
- Kevin VarnerHouston$1.1M
- Paul KimDallas$928K
- Sherman NaglerHouston$602K
- John EarlyDallas$553K
- Michael DowneySouthlake$475K
- Abdul NurudeenHouston$404K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.